がんホルモン療法剤の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE1957)
◆英語タイトル:Global Cancer Hormone Therapy Drugs Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE1957
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:109
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、がんホルモン療法剤の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(タモキシフェン、アロマターゼ阻害剤、抗アンドロゲン剤、アンドロゲン合成阻害剤、その他)、用途別市場規模(乳がん、前立腺がん)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・がんホルモン療法剤の市場動向
・企業の競争状況、市場シェア
・がんホルモン療法剤の種類別市場規模(タモキシフェン、アロマターゼ阻害剤、抗アンドロゲン剤、アンドロゲン合成阻害剤、その他)
・がんホルモン療法剤の用途別市場規模(乳がん、前立腺がん)
・がんホルモン療法剤の北米市場規模2016-2027(アメリカ、カナダ)
・がんホルモン療法剤の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・がんホルモン療法剤のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・がんホルモン療法剤の中南米市場規模2016-2027(メキシコ、ブラジル)
・がんホルモン療法剤の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Roche、Amgen、Pfizer、Teva、Takeda、Samyang Biopharmaceuticals、Tolmar、AstraZeneca、Novartis、Aspen)
・結論
【レポートの概要】

Hormone Therapy, (also called hormonal therapy, hormone treatment, or endocrine therapy) is a cancer treatment that blocks or lowers the growth of cancer that uses hormones to grow. Doctors use it to treat some cancers such as breast and prostate cancer.

Market Analysis and Insights: Global Cancer Hormone Therapy Drugs Market
The global Cancer Hormone Therapy Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Hormone Therapy Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Hormone Therapy Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Hormone Therapy Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Hormone Therapy Drugs market.

Global Cancer Hormone Therapy Drugs Scope and Market Size
Cancer Hormone Therapy Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Hormone Therapy Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Tamoxifen
Aromatase Inhibitors
Antiandrogens
Androgen Synthesis Inhibitors
Other

Segment by Application
Breast Cancer
Prostate Cancer

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche
Amgen
Pfizer
Teva
Takeda
Samyang Biopharmaceuticals
Tolmar
AstraZeneca
Novartis
Aspen

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Hormone Therapy Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tamoxifen
1.2.3 Aromatase Inhibitors
1.2.4 Antiandrogens
1.2.5 Androgen Synthesis Inhibitors
1.2.6 Other
1.3 Market by Application
1.3.1 Global Cancer Hormone Therapy Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Cancer Hormone Therapy Drugs Market Perspective (2016-2027)
2.2 Cancer Hormone Therapy Drugs Growth Trends by Regions
2.2.1 Cancer Hormone Therapy Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cancer Hormone Therapy Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Cancer Hormone Therapy Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Cancer Hormone Therapy Drugs Industry Dynamic
2.3.1 Cancer Hormone Therapy Drugs Market Trends
2.3.2 Cancer Hormone Therapy Drugs Market Drivers
2.3.3 Cancer Hormone Therapy Drugs Market Challenges
2.3.4 Cancer Hormone Therapy Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Cancer Hormone Therapy Drugs Players by Revenue
3.1.1 Global Top Cancer Hormone Therapy Drugs Players by Revenue (2016-2021)
3.1.2 Global Cancer Hormone Therapy Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Cancer Hormone Therapy Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cancer Hormone Therapy Drugs Revenue
3.4 Global Cancer Hormone Therapy Drugs Market Concentration Ratio
3.4.1 Global Cancer Hormone Therapy Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Hormone Therapy Drugs Revenue in 2020
3.5 Cancer Hormone Therapy Drugs Key Players Head office and Area Served
3.6 Key Players Cancer Hormone Therapy Drugs Product Solution and Service
3.7 Date of Enter into Cancer Hormone Therapy Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Hormone Therapy Drugs Breakdown Data by Type
4.1 Global Cancer Hormone Therapy Drugs Historic Market Size by Type (2016-2021)
4.2 Global Cancer Hormone Therapy Drugs Forecasted Market Size by Type (2022-2027)

5 Cancer Hormone Therapy Drugs Breakdown Data by Application
5.1 Global Cancer Hormone Therapy Drugs Historic Market Size by Application (2016-2021)
5.2 Global Cancer Hormone Therapy Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Cancer Hormone Therapy Drugs Market Size (2016-2027)
6.2 North America Cancer Hormone Therapy Drugs Market Size by Type
6.2.1 North America Cancer Hormone Therapy Drugs Market Size by Type (2016-2021)
6.2.2 North America Cancer Hormone Therapy Drugs Market Size by Type (2022-2027)
6.2.3 North America Cancer Hormone Therapy Drugs Market Size by Type (2016-2027)
6.3 North America Cancer Hormone Therapy Drugs Market Size by Application
6.3.1 North America Cancer Hormone Therapy Drugs Market Size by Application (2016-2021)
6.3.2 North America Cancer Hormone Therapy Drugs Market Size by Application (2022-2027)
6.3.3 North America Cancer Hormone Therapy Drugs Market Size by Application (2016-2027)
6.4 North America Cancer Hormone Therapy Drugs Market Size by Country
6.4.1 North America Cancer Hormone Therapy Drugs Market Size by Country (2016-2021)
6.4.2 North America Cancer Hormone Therapy Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Cancer Hormone Therapy Drugs Market Size (2016-2027)
7.2 Europe Cancer Hormone Therapy Drugs Market Size by Type
7.2.1 Europe Cancer Hormone Therapy Drugs Market Size by Type (2016-2021)
7.2.2 Europe Cancer Hormone Therapy Drugs Market Size by Type (2022-2027)
7.2.3 Europe Cancer Hormone Therapy Drugs Market Size by Type (2016-2027)
7.3 Europe Cancer Hormone Therapy Drugs Market Size by Application
7.3.1 Europe Cancer Hormone Therapy Drugs Market Size by Application (2016-2021)
7.3.2 Europe Cancer Hormone Therapy Drugs Market Size by Application (2022-2027)
7.3.3 Europe Cancer Hormone Therapy Drugs Market Size by Application (2016-2027)
7.4 Europe Cancer Hormone Therapy Drugs Market Size by Country
7.4.1 Europe Cancer Hormone Therapy Drugs Market Size by Country (2016-2021)
7.4.2 Europe Cancer Hormone Therapy Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Cancer Hormone Therapy Drugs Market Size (2016-2027)
8.2 Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Type
8.2.1 Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Application
8.3.1 Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Region
8.4.1 Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Cancer Hormone Therapy Drugs Market Size (2016-2027)
9.2 Latin America Cancer Hormone Therapy Drugs Market Size by Type
9.2.1 Latin America Cancer Hormone Therapy Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Cancer Hormone Therapy Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Cancer Hormone Therapy Drugs Market Size by Type (2016-2027)
9.3 Latin America Cancer Hormone Therapy Drugs Market Size by Application
9.3.1 Latin America Cancer Hormone Therapy Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Cancer Hormone Therapy Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Cancer Hormone Therapy Drugs Market Size by Application (2016-2027)
9.4 Latin America Cancer Hormone Therapy Drugs Market Size by Country
9.4.1 Latin America Cancer Hormone Therapy Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Cancer Hormone Therapy Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Cancer Hormone Therapy Drugs Market Size (2016-2027)
10.2 Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Type
10.2.1 Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Application
10.3.1 Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Country
10.4.1 Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Cancer Hormone Therapy Drugs Introduction
11.1.4 Roche Revenue in Cancer Hormone Therapy Drugs Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Cancer Hormone Therapy Drugs Introduction
11.2.4 Amgen Revenue in Cancer Hormone Therapy Drugs Business (2016-2021)
11.2.5 Amgen Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Cancer Hormone Therapy Drugs Introduction
11.3.4 Pfizer Revenue in Cancer Hormone Therapy Drugs Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Teva
11.4.1 Teva Company Details
11.4.2 Teva Business Overview
11.4.3 Teva Cancer Hormone Therapy Drugs Introduction
11.4.4 Teva Revenue in Cancer Hormone Therapy Drugs Business (2016-2021)
11.4.5 Teva Recent Development
11.5 Takeda
11.5.1 Takeda Company Details
11.5.2 Takeda Business Overview
11.5.3 Takeda Cancer Hormone Therapy Drugs Introduction
11.5.4 Takeda Revenue in Cancer Hormone Therapy Drugs Business (2016-2021)
11.5.5 Takeda Recent Development
11.6 Samyang Biopharmaceuticals
11.6.1 Samyang Biopharmaceuticals Company Details
11.6.2 Samyang Biopharmaceuticals Business Overview
11.6.3 Samyang Biopharmaceuticals Cancer Hormone Therapy Drugs Introduction
11.6.4 Samyang Biopharmaceuticals Revenue in Cancer Hormone Therapy Drugs Business (2016-2021)
11.6.5 Samyang Biopharmaceuticals Recent Development
11.7 Tolmar
11.7.1 Tolmar Company Details
11.7.2 Tolmar Business Overview
11.7.3 Tolmar Cancer Hormone Therapy Drugs Introduction
11.7.4 Tolmar Revenue in Cancer Hormone Therapy Drugs Business (2016-2021)
11.7.5 Tolmar Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Cancer Hormone Therapy Drugs Introduction
11.8.4 AstraZeneca Revenue in Cancer Hormone Therapy Drugs Business (2016-2021)
11.8.5 AstraZeneca Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Cancer Hormone Therapy Drugs Introduction
11.9.4 Novartis Revenue in Cancer Hormone Therapy Drugs Business (2016-2021)
11.9.5 Novartis Recent Development
11.10 Aspen
11.10.1 Aspen Company Details
11.10.2 Aspen Business Overview
11.10.3 Aspen Cancer Hormone Therapy Drugs Introduction
11.10.4 Aspen Revenue in Cancer Hormone Therapy Drugs Business (2016-2021)
11.10.5 Aspen Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ がんホルモン療法剤の世界市場規模・現状・予測2021年-2027年(Global Cancer Hormone Therapy Drugs Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。